[New antidiabetic drugs: current status and future prospects - a review of the literature].
425 million people worldwide suffer from diabetes. In patients with diabetes, insufficient glycemic control is associated with a high risk of developing micro- and macrovascular complications. The last decade has significantly contributed to extending the range of therapeutic options in the treatment of type 2 diabetes with new drugs that mimic ormodulate physiological processes in the human body. The paper summarizes the most important conclusions regarding the use of four groups of new drugs: thiazolidinediones, analogues of glucagon-like peptide 1, dipeptidyl peptidase-4 inhibitors and glucose-sodium 2 glucose cotransporter inhibitors, based on a review of the latest literature. These drugs have an anti-hyperglycemic effect and have numerous beneficial pleiotropic effects, including a safe cardiovascular profile. However, many of the mechanisms of action and effects of therapy, including side effects, new antidiabetic drugs remain unclear and require further clinical trials.